QuidelOrtho Corporation Share Price
Equities
QDEL
US2197981051
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.66 USD | +0.90% |
|
+3.48% | +17.75% |
| Capitalization | 2.27B 1.95B 1.82B 1.69B 3.15B 205B 3.39B 20.88B 8.2B 97.81B 8.5B 8.32B 361B | P/E ratio 2025 * |
-2.2x | P/E ratio 2026 * | -43.3x |
|---|---|---|---|---|---|
| Enterprise value | 4.51B 3.88B 3.62B 3.36B 6.27B 408B 6.76B 41.57B 16.33B 195B 16.92B 16.57B 718B | EV / Sales 2025 * |
1.67x | EV / Sales 2026 * | 1.54x |
| Free-Float |
98.54% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: QuidelOrtho Corporation
| 1 day | +0.90% | ||
| 1 week | +3.48% | ||
| Current month | +17.75% | ||
| 1 month | +15.73% | ||
| 3 months | +27.82% | ||
| 6 months | +16.53% | ||
| Current year | +17.75% |
| 1 week | 31.83 |  | 34.45 |
| 1 month | 27.93 | | 34.45 |
| Current year | 27.93 | | 34.45 |
| 1 year | 19.5 | | 46.24 |
| 3 years | 19.5 | | 98.67 |
| 5 years | 19.5 | | 265 |
| 10 years | 13.21 | | 306.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Blaser
CEO | Chief Executive Officer | 61 | 05/05/2024 |
Joseph Busky
DFI | Director of Finance/CFO | 58 | - |
Philip McLellan
COO | Chief Operating Officer | 57 | 14/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenneth Buechler
CHM | Chairman | 72 | 10/12/2022 |
Evelyn Dilsaver
BRD | Director/Board Member | 71 | 31/12/2021 |
Mary Polan
BRD | Director/Board Member | 82 | 31/12/1992 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -4.03% | 14.24% | 303 M€ | |
| 0.00% | 1.92% | 2 M€ | |
| 0.00% | 1.62% | 5 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.90% | +3.48% | -24.61% | -60.24% | 2.27B | |
| -0.19% | +2.04% | +6.74% | -35.80% | 18.71B | |
| +0.84% | +15.38% | +176.33% | +165.66% | 3.1B | |
| -0.55% | +7.38% | +3.19% | -0.74% | 1.19B | |
| -0.79% | +4.90% | +18.54% | -35.66% | 929M | |
| +0.95% | +6.33% | +23.36% | -45.28% | 935M | |
| -0.44% | +2.26% | -11.66% | -38.92% | 707M | |
| +0.64% | +5.93% | +0.15% | -35.27% | 558M | |
| -1.32% | -1.42% | +167.94% | - | 442M | |
| -0.51% | +4.52% | -22.94% | -27.22% | 411M | |
| Average | +0.03% | +5.04% | +33.70% | -12.61% | 2.92B | |
| Weighted average by Cap. | +0.18% | +4.14% | +24.48% | -14.86% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.71B 2.33B 2.17B 2.02B 3.76B 244B 4.06B 24.94B 9.8B 117B 10.15B 9.94B 431B | 2.77B 2.38B 2.22B 2.06B 3.85B 250B 4.15B 25.51B 10.02B 120B 10.38B 10.17B 441B |
| Net income | -1.03B -886M -826M -768M -1.43B -93.14B -1.54B -9.5B -3.73B -44.51B -3.87B -3.79B -164B | -52.74M -45.32M -42.26M -39.27M -73.27M -4.76B -79.01M -486M -191M -2.28B -198M -194M -8.39B |
| Net Debt | 2.25B 1.93B 1.8B 1.67B 3.12B 203B 3.36B 20.69B 8.13B 96.93B 8.42B 8.25B 357B | 1.99B 1.71B 1.6B 1.48B 2.77B 180B 2.99B 18.36B 7.21B 86.01B 7.47B 7.32B 317B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/01/26 | 33.61 $ | +0.75% | 354,321 |
| 12/01/26 | 33.36 $ | -0.85% | 978,153 |
| 09/01/26 | 33.64 $ | +0.40% | 1,196,408 |
| 08/01/26 | 33.51 $ | +0.42% | 886,306 |
| 07/01/26 | 33.37 $ | +2.68% | 1,333,814 |
Delayed Quote Nasdaq, January 13, 2026 at 07:48 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- QDEL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition